SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma.
Su, Jung-Chen
SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma. [electronic resource] - Neoplasia (New York, N.Y.) Jul 2014 - 595-605 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5586
10.1016/j.neo.2014.06.005 doi
Animals
Apoptosis--drug effects
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
Cell Proliferation
Cell Survival--drug effects
DNA-Binding Proteins--genetics
Disease Models, Animal
Drug Resistance, Neoplasm
Drug Synergism
Humans
Liver Neoplasms--drug therapy
Male
Mice
Niacinamide--analogs & derivatives
Phenylurea Compounds--pharmacology
Protein Tyrosine Phosphatase, Non-Receptor Type 6--genetics
Pyrroles--pharmacology
Regulatory Factor X Transcription Factors
Regulatory Factor X1
STAT3 Transcription Factor--metabolism
Sorafenib
Transcription Factors--genetics
Tumor Stem Cell Assay
Xenograft Model Antitumor Assays
SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma. [electronic resource] - Neoplasia (New York, N.Y.) Jul 2014 - 595-605 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5586
10.1016/j.neo.2014.06.005 doi
Animals
Apoptosis--drug effects
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
Cell Proliferation
Cell Survival--drug effects
DNA-Binding Proteins--genetics
Disease Models, Animal
Drug Resistance, Neoplasm
Drug Synergism
Humans
Liver Neoplasms--drug therapy
Male
Mice
Niacinamide--analogs & derivatives
Phenylurea Compounds--pharmacology
Protein Tyrosine Phosphatase, Non-Receptor Type 6--genetics
Pyrroles--pharmacology
Regulatory Factor X Transcription Factors
Regulatory Factor X1
STAT3 Transcription Factor--metabolism
Sorafenib
Transcription Factors--genetics
Tumor Stem Cell Assay
Xenograft Model Antitumor Assays